A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
Medicare is big business, recently providing healthcare coverage to 68 million people. It changes a little or a lot every ...
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.
The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
The White House has made it clear that Social Security and Medicare won't be affected by a proposed federal funding freeze. This freeze appeared to be off the table, after the initial OMB memo calling ...
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
The combination of just Medicare premiums and co-pays “eat up about one-third of Social Security income and one-fifth of ...
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...